Severe Hyperammonemic Encephalopathy Following Sustained-Release Sodium Valproate Overdose: A Case Report
Shotaro Ban, Chiaki Toida, Maiko Yamazaki, Masafumi Yoshida, Takahiro Onuki, Naoto Morimura · 2026
Read Severe Hyperammonemic Encephalopathy Following Sustained-Release Sodium Valproate Overdose: A Case Report by Shotaro Ban, Chiaki Toida, Maiko Yamazaki, Masafumi Yoshida, Takahiro Onuki, Naoto Morimura (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13179122.txt.
Description
A peer-reviewed research article from Europe PMC (2026). Although valproate-induced hyperammonemia is a common adverse effect, it is rarely associated with potentially fatal encephalopathy. A 22-year-old female with a disturbance of consciousness presented to the emergency department after taking an overdose of sustained-release sodium valproate. Initial laboratory testing demonstrated no evidence of hepatic dysfunction, including normal serum transaminases and coagulation parameters, elevated serum ammonia (88 μg/dL), and serum valproate levels (645 μg/dL). The patient was intubated and underwent gastric lavage, followed by multi-dose activated charcoal and lactulose.
Catalog record
| CREATOR | Shotaro Ban, Chiaki Toida, Maiko Yamazaki, Masafumi Yoshida, Takahiro Onuki, Naoto Morimura |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 15 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |